M. Achmatowicz, J. Jurczak / Tetrahedron: Asymmetry 12 (2001) 487–495
493
55.6, 54.6, 53.9, 53.8, 53.4, 51.7, 40.9, 38.7, 38.6, 30.7,
30.6, 29.3, 28.0, 27.8, 27.7, 26.3, 26.2, 26.0, 24.2, 23.2;
IR (CHCl3): w=3453, 3344, 3007, 2947, 2868, 2814,
1721, 1659, 1521, 1455 cm−1; MS (EI HR): calcd for
[C36H58N6O6]+ 670.44178, found 670.44270.
4.3.4. (7S,17S,27S)-1,5,11,15,21,25-Hexaazatetracyclo-
[25.3.0.07,11.017,21]triacontane-6,16,26-trione 5b. Mp 151–
153°C; [h]2D0=−68.5 (c 1.9, CHCl3); 1H NMR (500
MHz, d8-toluene, 90°C, TMS): l=6.85 (bs, 3H; 3×
NH), 3.28–3.17 (m, 6H; 3×NHCH2), 2.91 (ddd, 3H,
J1=2.9 Hz, J2=7.0 Hz, J3=9.5 Hz; 3×NCHH), 2.86
(dd, 3H, J1=5.6 Hz, J2=9.3 Hz; 3×CHCO), 2.46 (dt,
3H, J1=7.6 Hz, J2=12.4 Hz; 3×NCHH), 2.21 (ddd,
3H, J1=5.7 Hz, J2=7.0 Hz, J3=12.5 Hz; 3×NCHH),
1.99 (dt, 3H, J1=7.0 Hz, J2=9.3 Hz; 3×NCHH), 1.94–
1.79 (m, 6H; 3×CH2), 1.58–1.38 (m, 12H; 6×CH2); 13C
NMR (125 MHz, d8-toluene, 90°C, TMS): l=173.6,
69.1, 55.2, 54.8, 38.0, 30.8, 30.4, 24.5; IR (CHCl3):
w=3341, 2948, 2821, 1660, 1518 cm−1; MS (EI HR):
calcd for [C24H42N6O3]+ 462.33184, found 462.33206.
Anal. calcd for C24H42N6O3: C, 62.34; H, 9.09; N,
18.18. Found: C, 62.06; H, 8.94; N, 18.26%.
4.3. Macrocyclisation procedures (345)
N-Cbz-Protected aminoesters 3a–c were subjected to
catalytic hydrogenation (H2 over 5% Pd–C in
methanol) affording aminoesters 4a–c, which were used
without further purification for subsequent macrocycli-
sation reactions.
4.3.1. Macrocyclisation reactions (45) promoted by
basic additives (NaOMe, NaOH, DBU, or TBAOH).
The following procedure for the macrocyclisation
employing sodium methoxide is representative for all
reactions promoted by basic additives. Aminoester 4
(1.87 mmol) was dissolved in NaONa solution in
methanol (0.4 M, 0.19 L), and allowed to stand at room
temperature for 30 days (for DBU and TBAOH pro-
moted reactions 10 equiv. of base were used). The
reaction mixture was neutralised with aq. HCl and
evaporated to dryness. The solid residue was dissolved
in water (20 mL) and extracted with CHCl3 (4×20 mL).
The combined chloroform extracts were dried (Na2SO4)
and the solvent was evaporated. Chromatographic
purification (CH2Cl2/methanol=9/1) followed by
recrystallisation from CH2Cl2/Et2O afforded the macro-
cyclic triamide 5 as colourless crystals.
4.3.5. (8S,19S,30S)-1,6,12,17,23,28-Hexaazatetracyclo-
[28.3.0.08,12.019,23]triacontane-7,18,29-trione 5c. Mp 151–
153°C; [h]2D0=−152 (c 0.50, CHCl3); 1H NMR (500
MHz, CDCl3, 30°C, TMS): l=7.35 (bt, 3H, J=5.6 Hz;
3×NH), 3.50–3.42 (m, 3H; 3×NHCHH), 3.15 (dt, 3H,
J1=1.4 Hz, J2=7.8 Hz; 3×NCHH), 3.12–3.05 (m, 3H;
3×NHCHH), 3.01 (dd, 3H, J1=4.8 Hz, J2=10.1 Hz;
3×CHCO), 2.61 (dt, 3H, J1=7.6 Hz, J2=11.9 Hz;
3×NCHH), 2.49–2.43 (m, 3H; 3×NCHH), 2.32–2.25
(m, 3H; NCHH), 2.22–2.17 (m, 3H; 3×CHH), 1.88–
1.77 (m, 6H; 3×CHH, 3×CHH), 1.75–1.61 (m, 6H;
3×CHH, 3×CHH), 1.54–1.41 (m, 9H; 3×CH2, 3×
CHH); 13C NMR (125 MHz, CDCl3, 30°C, TMS):
l=174.7, 68.0, 55.6, 53.7, 38.6, 30.4, 27.9, 26.4, 24.2;
IR (CHCl3): w=3345, 2942, 2864, 2817, 1660, 1523,
1460 cm−1; MS (EI HR): calcd for [C27H48N6O3]+
504.37879, found 504.37919.
4.3.2. Macrocyclisation reactions (45) carried out
under high pressure conditions. A solution of the
aminoester 4 (0.409 mmol) in methanol (2.5 mL) was
added to a Teflon® ampoule, placed in a high-pressure
vessel filled with ligroin as a transmission medium and
compressed (10 kbar or 16 kbar) at 50°C for 7 days.
After decompression, the mixture was transferred quan-
titatively to a round-bottomed flask and the solvent was
evaporated. The crude product was purified by column
chromatography on silica (CH2Cl2/methanol=9/1), fol-
lowed by recrystallisation from CH2Cl2/Et2O, to afford
the macrocyclic triamide 5 as colourless crystals.
4.4. Reduction of the macrocyclic triamides (56)
4.4.1. (7S,17S,27S)-1,5,11,15,21,25-Hexaazatetracyclo-
[25.3.0.07,11.017,21]triacontane 6b. The following proce-
dure for amide reduction is representative. To a vigor-
ously stirred suspension of 5b (102 mg, 0.220 mmol) in
dry THF (10 mL) under argon, BH3·Me2S complex (10
M, 0.66 mL, 6.6 mmol) was added dropwise. For a
short period of time the reaction mixture turned into a
clear solution. The reaction mixture was then stirred at
reflux overnight (19 h), cooled to room temperature,
and a mixture of THF/water=4/1 (5 mL) was carefully
added. The mixture was evaporated to dryness. The
residue was taken up in aq. HCl (6 M, 10 mL) and
the suspension stirred under reflux until a clear
solution was seen (ca. 1 h). The mixture was eva-
porated to dryness and the solid residue was dissolved
in aq. NaOH (4 M, 5 mL) and extracted with CHCl3
(5×10 mL). The combined extracts were dried
(Na2SO4) and evaporated. Chromatographic purifica-
tion of the crude product (methanol/aq. NH3=9/1)
afforded the title compound (65 mg, 70% yield) as a
4.3.3. (6S,15S,24S)-1,4,10,13,19,22-Hexaazatetracyclo-
[22.3.0.06,10.015,19]heptacosane-5,14,23-trione 5a. Mp
1
224–225°C; [h]2D0=−149 (c 1.8, CHCl3); H NMR (500
MHz, CDCl3, 30°C, TMS): l=7.43 (bs, 3H; 3×NH),
3.57–3.49 (m, 3H; 3×NHCHH), 3.29–3.22 (m, 3H; 3×
NHCHH), 3.16–3.08 (m, 6H; 3×NCHH, 3×CHCO),
2.89 (ddd, 3H, J1=4.8 Hz, J2=8.1 Hz, J3=12.7 Hz;
NCHH), 2.64 (dt, 3H, J1=5.1 Hz, J2=12.6 Hz; 3×
NCHH), 2.42 (dt, 3H, J1=9.5 Hz, J2=6.8 Hz; 3×
NCHH), 2.25–2.14 (m, 3H; 3×CHH), 1.94–1.87 (m,
3H; 3×CHH), 1.86–1.77 (m, 3H; 3×CHH), 1.74–1.63
(m, 3H; 3×CHH); 13C NMR (125 MHz, CDCl3, 30°C,
TMS): l=174.7, 67.9, 54.7, 54.1, 38.5, 30.1, 23.9; IR
(CHCl3): w=3347, 2822, 1663, 1524, 1450 cm−1; MS
(ESI HR): calcd for [C21H37N6O3]+ 421.2922, found
421.2914. Anal. calcd for C21H36N6O3: C, 60.00; H,
8.57; N, 20.00. Found: C, 59.75; H, 8.42; N, 19.77%.
1
colourless oil; [h]D20=−88.1 (c 0.57, CHCl3); H NMR
(500 MHz, CDCl3, 30°C, TMS): l=3.18–3.15 (m, 3H;
3×NCHH), 2.81 (dt, 3H, J1=8.1 Hz, J2=12.0 Hz;
3×NHCHH), 2.71–2.61 (m, 9H; 3×CHCH2NH, 3×
NCHH), 2.58–2.47 (m, 6H; 3×NCHH, 3×CH), 2.25